Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Memorial Sloan Kettering Cancer Center
MedTech
AstraZeneca EBV study finds 22 genes tied to chronic disease
Nine in 10 people worldwide have been infected with Epstein-Barr virus. Only a few will go on to develop illnesses that have been linked to the virus.
Natalie Missakian
Feb 2, 2026 6:05am
AZ, MSK adopt tech firm's data capture tool for phase 3 trial
Apr 1, 2025 3:05pm
Absci inks AI R&D collab with Memorial Sloan Kettering
Aug 12, 2024 2:00pm
AI model from NIH, MSKCC predicts immunotherapy responses: study
Jun 4, 2024 12:42pm
Sophia Genetics taps AstraZeneca, MSK to spread cancer tests
Oct 19, 2023 12:58pm
Reprogramming new T cell for immunotherapy cancer treatment
Apr 25, 2022 9:30am
